tiprankstipranks
Silverback Therapeutics (SBTX)
NASDAQ:SBTX
US Market

Silverback Therapeutics (SBTX) Stock Investors

0 Followers
Based on 581,866 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold SBTX
On average, investors allocate 3.22% of their portfolios to SBTX
The average holding size of this company in investors' portfolios.

Investor Sentiment

Neutral
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 581,866 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding SBTX

2.3%
Last 7
Days
2.3%
Last 30
Days
Percentages indicate the change in the number of portfolios holding SBTX, out of 581,866 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

SBTX Investor Activity

Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Increased
<0.01%
$6.15
Increased
<0.01%
$4.91
Based on the activity of 11,039 investors who made their portfolios public
The table shows changes in SBTX in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

SBTX Investors Also Bought

Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
JD
4.08%
+0.32%
+1.04%
76.71B
Consumer Goods
Novavax
4.45%
-0.69%
-1.58%
1.97B
Healthcare
Syros Pharmaceuticals
3.57%
-0.69%
-2.80%
80.54M
Healthcare
Fuelcell Energy
3.97%
-0.34%
-1.06%
1.48B
Technology
Peloton Interactive
3.05%
-0.83%
-2.09%
3.48B
Services
ServiceNow
3.50%
-0.25%
+2.40%
82.97B
Technology
C3ai
3.36%
-0.49%
-1.34%
1.62B
Technology
Crispr Therapeutics AG
3.98%
-0.58%
-2.09%
4.73B
Healthcare
BioNano Genomics
4.78%
-0.20%
-0.90%
789.82M
Healthcare
Digital Turbine
3.90%
-0.26%
-1.04%
1.90B
Technology
Based on the activity of 581,866 active portfolios
Open your Smart Portfolio

SBTX Investor Analysis

SBTX investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
31.3%
of SBTX holders
are under 35
Average Segment Performance
Average P/E Ratio7.16
Beta1.16
Dividend Yield4.40%
SBTX investors between 35–55

Between 35–55

12.4%
Last 30 days
Holdings Change
53.1%
of SBTX holders
are between 35–55
Average Segment Performance
Average P/E Ratio5.16
Beta1.23
Dividend Yield5.23%
SBTX investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
15.6%
of SBTX holders
are over 55
Average Segment Performance
Average P/E Ratio7.88
Beta0.98
Dividend Yield4.44%
Overview of age group and performance of SBTX stock investors
See who invests in SBTX according to age group and performance.

FAQ

How many retail Investors hold SBTX?
<0.1% of TipRanks' retail investors hold SBTX in their portfolios.
    What is SBTX Investor Sentiment?
    SBTX’s Investor Sentiment is Neutral.
      What percentage of retail investors changed their holding of SBTX in the last 7 days?
      ▼ 2.3% of TipRanks' retail investors changed their holding of SBTX in the last 7 days.
        What percentage of retail investors changed their holding of SBTX in the last 30 days?
        ▲ 2.3% of TipRanks' retail investors changed their holding of SBTX in the last 30 days.
          What is the average age of retail investors who hold SBTX?
          The average age of SBTX Holders is between 35–55.
            What other stocks have SBTX investors also bought?
            SBTX Investors also bought JD, NVAX, SYRS, FCEL, PTON, NOW, AI, CRSP, BNGO, APPS.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              AGENAgenus
              ABCAmerisourceBergen
              AMGNAmgen
              BIIBBiogen
              BIOBio-Rad Laboratories
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis